Premium
Malladi Drugs and Pharmaceuticals Ltd, which is backed by healthcare-focused private equity firm InvAscent, is seeking to accelerate business growth as it plans to explore the possibility of floating an initial public offering in the next financial year, VCCircle has gathered. The contract manufacturer of bulk drugs recorded a drop in revenue ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
